Title : CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.

Pub. Date : 1995 May 16

PMID : 7538976






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the surviving breast cancer patients there was a significant decrease in the percentage of non-B lymphocyte HLA-DR+ (CD20-HLA-DR+) cells following cyclophosphamide treatment. Cyclophosphamide keratin 20 Homo sapiens
2 Breast cancer patients who showed a greater than median decrease in CD20-HLA-DR+ lymphocytes following cyclophosphamide treatment had a survival advantage over patients who had less than the median decrease in the percent CD20-HLA-DR+ lymphocytes. Cyclophosphamide keratin 20 Homo sapiens
3 Breast cancer patients who showed a greater than median decrease in CD20-HLA-DR+ lymphocytes following cyclophosphamide treatment had a survival advantage over patients who had less than the median decrease in the percent CD20-HLA-DR+ lymphocytes. Cyclophosphamide keratin 20 Homo sapiens